NYBC Ventures Overview

For Profit. For Purpose.

We are NYBC Ventures, the first venture fund solely dedicated to advancing innovation in blood-related and cellular medicines and technologies.

Our Areas of Interest

Taking an agnostic approach to financing vehicles and structures and employing a model of patient capital, we have developed streamlined scientific and investment due diligence teams to evaluate investment and collaborative opportunities in the following areas:

  • Benign hematology
  • Infectious diseases
  • Transfusion medicine
  • Cell therapy
  • Regenerative medicine

Capitalizing on New York Blood Center’s 50+ year history of providing high-quality, cutting-edge blood products and transfusion services to leading medical institutions, we leverage NYBC’s enterprise-wide leadership, infrastructure, resources, and unparalleled expertise and talent to explore and fund synergistic investment and collaborative opportunities:

Lindsley F. Kimball Research Institute (LFKRI)

Comprehensive Cell Solutions (CCS)

Connect with Us

To learn more about NYBC Ventures, please contact Meg Wood, Vice President of Ventures and Business Development.

CONTACT